Evolus EOLS
NASDAQ EOLS
$7.48 +0.06 (+0.81%)
As of: Nov 12, 2026 · 9:55 AM EST

Evolus (EOLS) Return on Invested Capital [ROIC] (2018 - 2026)

Updated

Evolus' Return on Invested Capital [ROIC] was -12.74% in Q3 2026, up 19.41 percentage points from -32.15% a year earlier and up 1.99 percentage points from the prior quarter.

Analysis

Evolus (EOLS) Return on Invested Capital [ROIC] (2018 - 2026) Analysis & Trends

For FY2025, Return on Invested Capital [ROIC] at Evolus came in at -26.13%, up 4.23 percentage points from FY2024.

  • Return on Invested Capital [ROIC] has now increased for three consecutive years, with a five-year change of +150.36 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Invested Capital [ROIC] was -30.36% in FY2024 (+21.45 pp), -51.81% in FY2023 (+1.85 pp), -53.66% in FY2022 (-2.50 pp) and -51.16% in FY2021 (+125.33 pp).
  • The Q3 2026 figure marks the highest quarterly Return on Invested Capital [ROIC] since Q1 2018.
  • Compared with a year earlier, Return on Invested Capital [ROIC] has increased for three straight quarters, with an average year-over-year change of +9.86 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was Q1 2022 (a gain of 357.32 percentage points); the worst was Q4 2022 (a drop of 35.46 percentage points).
  • Per Business Quant data, EOLS's Return on Invested Capital [ROIC] in the three quarters before Q3 2026 was -14.73% (Q2 2026), -19.42% (Q1 2026) and -27.22% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Evolus 450.43 Mn 259.94 Mn 50.69 Mn -12.74%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -12.74%
Jun 30, 2026 -14.73%
Mar 31, 2026 -19.42%
Dec 31, 2025 -27.22%
Sep 30, 2025 -32.15%
Jun 30, 2025 -35.67%
Mar 31, 2025 -33.57%
Dec 31, 2024 -27.08%
Sep 30, 2024 -30.47%
Jun 30, 2024 -27.71%
Mar 31, 2024 -38.63%
Dec 31, 2023 -56.14%
Sep 30, 2023 -62.64%
Jun 30, 2023 -66.75%
Mar 31, 2023 -73.12%
Dec 31, 2022 -68.30%
Sep 30, 2022 -66.31%
Jun 30, 2022 -57.53%
Mar 31, 2022 -46.54%
Dec 31, 2021 -32.84%
API Access

Evolus Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=EOLS&period=max&api_key=YOUR_API_KEY